Refractive Outcomes After Trabecular Micro-Bypass Stents (iStent Inject) with Cataract Extraction in Open-Angle Glaucoma by Ioannidis, Alexandros S et al.








Refractive Outcomes After Trabecular Micro-Bypass Stents (iStent Inject)
with Cataract Extraction in Open-Angle Glaucoma
Ioannidis, Alexandros S ; Töteberg-Harms, Marc ; Hamann, Timothy ; Hodge, Christopher
Abstract: Purpose Simultaneous cataract and glaucoma surgery has traditionally been challenging for
the anterior segment surgeon. The introduction of minimally invasive glaucoma surgery (MIGS) in
conjunction with cataract surgery appears safe and effective in lowering intraocular pressure. Although
a significant visual impact leading from the combined procedure is unexpected, we aim to describe
the refractive outcomes in a cohort of patients undergoing simultaneous cataract removal and iStent
inject and discuss the potential implications of combined surgery in patients with co-existent glaucoma.
Patients and Methods This is a retrospective consecutive case series inclusive of patients undergoing
combined femtosecond laser-assisted cataract surgery and the insertion of two trabecular micro-bypass
stents (iStent inject). Visual acuity, refraction and astigmatic vector analysis were collated and analysed
from the preoperative and 4 weeks postoperative visits. Results One hundred and six eyes of 89 patients
from 2 surgeons were included in the original cohort. The mean absolute difference from target refraction
was 0.36 ± 0.25D. 73.9% of eyes were within ± 0.5D of the refractive target and 98.9% of eyes were
within ± 1.00D. 73.8% of eyes had 0.5D or less residual refractive astigmatism following the procedure.
Conclusion We present a novel cohort of glaucoma patients undergoing combined trabecular micro-bypass
stents (iStent inject) and cataract surgery achieving excellent refractive outcomes. The results of this
study indicate that this second-generation device is refractively neutral.
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Purpose: Simultaneous cataract and glaucoma surgery has traditionally been challenging for
the anterior segment surgeon. The introduction of minimally invasive glaucoma surgery
(MIGS) in conjunction with cataract surgery appears safe and effective in lowering intrao-
cular pressure. Although a significant visual impact leading from the combined procedure is
unexpected, we aim to describe the refractive outcomes in a cohort of patients undergoing
simultaneous cataract removal and iStent inject and discuss the potential implications of
combined surgery in patients with co-existent glaucoma.
Patients and Methods: This is a retrospective consecutive case series inclusive of patients
undergoing combined femtosecond laser-assisted cataract surgery and the insertion of two
trabecular micro-bypass stents (iStent inject). Visual acuity, refraction and astigmatic vector
analysis were collated and analysed from the preoperative and 4 weeks postoperative visits.
Results: One hundred and six eyes of 89 patients from 2 surgeons were included in the
original cohort. The mean absolute difference from target refraction was 0.36 ± 0.25D.
73.9% of eyes were within ± 0.5D of the refractive target and 98.9% of eyes were within
± 1.00D. 73.8% of eyes had 0.5D or less residual refractive astigmatism following the
procedure.
Conclusion: We present a novel cohort of glaucoma patients undergoing combined trabe-
cular micro-bypass stents (iStent inject) and cataract surgery achieving excellent refractive
outcomes. The results of this study indicate that this second-generation device is refractively
neutral.
Keywords: glaucoma, cataract surgery, trabecular micro-bypass stents, astigmatism,
intraocular lenses
Introduction
Simultaneous cataract and glaucoma surgery represents a potential challenge for the
anterior segment surgeon.1 An option to reduce the surgical, anaesthetic and
recovery load, however, must be weighed against an elevated risk of intraoperative
complications and sub-optimal refractive outcomes in patients with concomitant
ocular disease.1–3 With recent developments in intraocular lens (IOL) and biometry
technology, stand-alone cataract surgery now provides a substantial opportunity to
increase optical independence and vision-related quality of life.4 Given this, patient
expectations have similarly increased. Despite often long-term ophthalmic care,
glaucoma patients would appear to hold similar expectations of an improved range
of vision following cataract surgery.5,6
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Trabeculectomy has long been considered the gold stan-
dard for glaucoma patients where medical and laser treat-
ments have been unable to control intraocular pressure
(IOP).7 Although trabeculectomy and other invasive glau-
coma surgical approaches provide a proven track record in
reducing and maintaining IOP, successful visual rehabilita-
tion may be compromised by surgically induced anatomical
changes leading to residual defocus and astigmatic errors.7–9
Alternative IOP-lowering procedures have become common-
place for glaucoma, and increasingly anterior segment
surgeons.10 Minimally invasive glaucoma surgery (MIGS)
techniques and similar non-penetrating options now repre-
sent the first surgical procedure of choice for patients with
mild- to- moderate glaucoma requiring additional
treatment.11With minimal or no additional need for conjunc-
tival suturing or the application of anti-metabolite treatment,
it would be expected that routine MIGS surgery should have
a nominal impact on refractive outcomes. A number of
studies have highlighted the safety and effectiveness of
MIGS procedures in reducing IOP however few have indi-
cated the refractive outcomes, particularly astigmatic
effects.8,12,13 We present a refractive cohort of patients
undergoing simultaneous glaucoma and cataract procedures
and discuss the potential implications of cataract surgery and
IOL implantation in patients with co-existent glaucoma.
Materials and Methods
This is a retrospective consecutive case series inclusive of
patients undergoing combined femtosecond laser-assisted
cataract surgery and the insertion of a minimally invasive
glaucoma implant (iStent inject, Glaukos, San Clemente,
CA, USA). One hundred and six eyes of 89 patients under-
going combined surgery were included in the initial cohort.
To assist internal validity, only one eye of a patient was
included in the final data analysis. The first eye undergoing
the procedure was chosen in the 17 bilateral patients.
Inclusion criteria required patients having undergone
successful cataract removal and insertion of an intraocular
lens (IOL) with a concomitant implant of iStent inject.
Patients were excluded from analysis in the presence of
intraoperative complications including but not limited to;
anterior or posterior capsular tear or the need for additional
intraoperative manipulation, e.g. use of pupil expander
devices. Patients who had previously undertaken glaucoma
or corneal refractive surgical procedures were removed from
data analysis. All patients were diagnosed prior to surgery
with primary open-angle glaucoma requiring additional IOP
reduction on the advice of the principal surgeon (AI/MTH).
Biometry was performed using an IOLMaster 500 or
an IOLMaster 700 (Zeiss, Jena, Germany). Based on sur-
geon choice, either the Barrett Universal II or Haigis IOL
power calculation formulae were used to determine the
postoperative refraction target in each case. Surgical pre-
treatment (capsulotomy and phacofragmentation) was per-
formed with a femtosecond laser (LenSx Alcon, Ft. Worth,
TX, USA) or a manual, curvilinear capsulorhexis was
performed followed by divide-and-conquer cataract sur-
gery. Both temporal and superior clear corneal incision
sites were utilised with a 2.4mm keratome. A single-
focus IOL was inserted in each case. The insertion of the
iStent inject device was undertaken following the cataract
procedure. The iStent inject is comprised of two heparin-
coated biocompatible implant-grade titanium stents pre-
loaded in a single-use injector. Each stent is inserted ab
internally through the nasal trabecular meshwork into
Schlemm’s canal. In all patients, a second stent was
implanted in the same manner approximately 2–3 clock
hours away from the first stent which is the norm.
The study was retrospective in nature and did not
require external human ethics approval for the Australian
center however was approved for the Swiss center by the
Cantonal Ethics Committee of the Kanton of Zurich (KEK
ZH 2019-00423). All patient data were anonymised prior
to statistical analysis. Additionally, all procedures were
followed in accordance with the ethical standards of the
responsible committee on human experimentation (institu-
tional or regional) or with the Helsinki Declaration of
1975, as revised in 1983.
Refractive data from the preoperative screening and both
1 day and 4 weeks post-surgery visits were collected and
analysed. Refraction was performed at pre and postoperative
evaluations by experienced technicians to ensure accuracy.
Refractive data were collated into a database (Excel,
Microsoft, Redmond, WA, USA), converted from diopters
into vectors and transferred to the statistics program for final
data analysis (V20.0, SPSS IBM, Chicago, IL, USA). This
includes the determination of J0 (the vector at Jackson cross-
cylinder axis 0°) and J45 (the vector at Jackson cross-
cylinder axis 45°). The Cartesian coordinates could then be
used for statistical comparison.14
Results
Eighty-nine eyes of 89 patients were included in the final
analysis. The mean age of the cohort was 73.3 ± 8.5 years
(range 57 to 90 years). Fifty-five of the patients were
female (61.8%). Almost two-thirds (59.1%) of procedures
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were undertaken in the right eye. The mean axial length
for the cohort was 23.79 ± 1.32mm (range 20.76 to
27.22mm) and mean anterior chamber depth 3.21 ±
0.47mm (range 1.82 to 4.57mm). Mean corneal astigma-
tism was 0.91 ± 0.76D (range 0.00 to 4.25D). Mean
medicated intraocular pressure (IOP) prior to surgery
16.16 ± 5.29mmHg (range 8 to 37mmHg).
Refraction and Visual Acuity
Refractive parameters are detailed in Table 1. The mean
arithmetic difference from spherical equivalent (SE) target
was −0.12 ± 0.42D (range −1.00 to 0.90D) whilst the mean
absolute difference from SE target refraction was 0.36 ±
0.25D (range 0.00 to 1.00D). There was no difference
between outcomes based on the location of the surgical
incision (e.g. superior vs temporal) for either mean or
absolute difference from SE target (p = 0.425, 0.735,
respectively). As indicated in Figure 1, 73.9% of eyes
were within ±0.5D of the refractive target with 98.9 eyes
within ±1.00D of the predicted refractive target.
There was no significant difference between pre and
postoperative spheres or SE however the mean reduction
in the refractive cylinder was statistically significant fol-
lowing surgery (p = 0.000). There was no significant
difference between right and left eyes for all measures (p
> 0.05). Approximately three-quarters (73.8%) of patients
achieved refractive astigmatism of 0.50D or less following
surgery (Figure 2). Cumulative visual acuity is represented
Table 1 Pre and Postoperative Refraction
n = 89 Preop Mean ± SD Range Postop Mean ± SD Range p value
Sphere −0.03 ± 2.63 −11.00 to 5.50D −0.13 ± 0.50 −1.25 to 1.75D 0.508
Cylinder −0.91 ± 0.76 −4.25 to 0.00D −0.41 ± 0.48 −1.50 to 0.00D <0.001
Spherical Equivalent (SE) −0.49 ± 2.64 −11.25 to 5.00D −0.31 ± 0.46 −1.25 to 1.63D 0.900
Abbreviations: D, diopters; SD, standard deviation.


































Figure 1 Attempted SE versus achieved SE for the cohort.
Dovepress Ioannidis et al



























































































Powered by TCPDF (www.tcpdf.org)
in Figure 3. Over ninety percent (95.4%) of eyes were able
to reach 20/40 uncorrected following surgeries.
Vector Analysis
Vector-based variables are included in Table 2. There was
a significant reduction in both J45 and B values only
following surgery. There was no difference in parameters
between right and left eyes for all variables. Similarly,
there was no statistically significant difference between
the change in J0 and J45 values with respect to main
incision location (e.g. superior vs temporal, p = 0.634,
0.296 for J0 and J45, respectively). Manifest astigmatism
represented by the astigmatism component of a power
vector (referenced to the spectacle plane) for before and
after surgery is provided in Figure 4.
Safety and Efficacy
There were no intraoperative complications requiring addi-
tional procedures. The mean treated intraocular pressure
(IOP) prior to surgery was 16.16 ± 5.29mmHg. The change
in treated IOP at the final visit was 1.86 ± 4.89mmHg
(range −12 to +5mmHg) with 26.7% of patients achieving
a reduction in IOP of 20% or greater from preop levels.
Almost 60% percent (59.3%) of patients maintained or
reduced their preop IOP value at the final visit. Forty-six
(83.6%) patients reduced their medication usage following
surgery, of these 7(12.7%) reduced multiple medications.
The reduction in IOP was significantly correlated with
the preoperative value (r = 0.603, p = 0.000). There was no
significant correlation between preoperative IOP, change
in IOP and difference from postoperative refractive target
(p > 0.05).
Discussion
Invasive glaucoma surgical procedures such as trabecu-
lectomy and drainage device implantation have been
shown to impact the axial length and keratometry mea-
surements following stand-alone surgery.2 Although
research has proposed the significant reduction of IOP
as the main contributing factor to biometry changes;
induction of corneal changes through the creation of the
scleral flap, use of sutures and wound gape have also been
indicated in several studies.9,15,16 Hypotony is usually


























































































Postoperative Refractive Cylinder (D)
Preop Refractive Cylinder Postop Refractive Cylinder
N = 89 eyes at 4 weeks postop
± 0.50D = 73.8%
± 1.00D = 88.7%
Figure 2 Cumulative refractive astigmatism at the final visit.
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within a relatively short period in the majority of trabe-
culectomy patients.17 This suggests that optimal refrac-
tive outcomes may be achieved through sequential
cataract and glaucoma procedures and once biometry
values are stable. Phacotrabeculectomy remains an appro-
priate option for some patients however refractive out-
come data is limited. Despite biometrical changes, Law
et al found no statistical difference in the difference from
the intended refractive outcome in a small comparative
cohort suggesting that structural surgical changes may not
clinically impact the refractive outcome.2 Of note, the
authors described a decrease in axial length and converse
increase in keratometry, which may have served to
balance the refractive changes. Increasing with-the-rule
(WTR) astigmatism following both trabeculectomy and
other invasive glaucoma procedures has been variably
described suggesting caution is still advisable.2 Given
the recent increase in toric intraocular lenses usage, this
may increase the risk profile for patients undergoing
a combined approach.18
Minimally Invasive Glaucoma Surgery (MIGS) has
been shown to be both safe and effective in reducing
IOP and the need for multiple topical medications in
patients with mild to moderate disease.10 Although cap-
able as a stand-alone procedure, MIGS is often incorpo-
rated within cataract surgery through regulatory
requirements. This does provide an opportunity for the
surgeon to reduce the burden of additional surgical proce-
dures and minimise recovery whilst providing the additive
effect in lowering IOP. Several publications have recently
shown that combined iStent inject implantation and catar-
act surgery significantly increased the success rate and
reduced the number of medications in glaucoma patients
compared to cataract surgery alone.19,20




































Cumulative Snellen Visual acuity (20/x or better) 
Preop CDVA
Postop UDVA
Figure 3 Cumulative snellen visual acuity.
Abbreviations: CDVA, corrected distance visual acuity; UDVA, uncorrected distance visual acuity.








J0 −0.04 ± 0.41 −0.01 ± 0.22 0.433
J45 −0.10 ± 0.43 0.03 ± 0.22 0.005
B 1.99 ± 2.09 0.62 ± 0.96 <0.001
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The refractive impact of MIGS upon associated catar-
act surgery is expected to be minimal however few, if any
studies have focused on visual outcomes.8 Manoharan and
co-authors found an increase in refractive surprises in
a subset of glaucoma patients undergoing cataract-MIGS
surgery against a non-glaucoma cataract-only comparative
cohort. The analysis did, however, include multiple MIGS
devices limiting a direct comparison to the current study.21
Arriola-Villalobos et al showed a significant increase of
mean LogMAR best corrected visual acuity from 0.42 ±
0.16 to 0.18 ± 0.16 following combined iStent inject and
cataract surgery at 3 years post-surgery.12 Using a single
trabecular micro-bypass stent implanted through the same
temporal, limbal incision used for cataract surgery,
Neuhann achieved best corrected of 20/40 or greater in
38 of 41 eyes (93%) at 3 years.13 In comparison, we found
95.4% of eyes greater or equal to 20/40 uncorrected dis-
tance visual acuity. Although these reports indicate visual
improvement, refractive correction was not identified.
Scott et al compared a cohort of 76 eyes undergoing
combined cataract and iStent procedures with a cataract-
only group. The authors showed no difference between
groups suggesting the initial iStent device remained refrac-
tively neutral. Scott et al found 80% and 95% of eyes were
within ± 0.5D and ±1.00D, respectively, highlighting
excellent possible refractive outcomes with the earlier
device.22 We found a mean absolute difference from SE
target refraction was 0.36 ± 0.25D with 73.9% of eyes
within 0.5D of the refractive target with 98.9 eyes within
1.00D of the predicted refractive target. This would appear
















Figure 4 Manifest astigmatism before and after surgery.
Abbreviations: J0, vector at Jackson cross-cylinder axis 0°; J45, vector at Jackson cross-cylinder axis 45°.
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to be similar to large cohort registry findings in standard
cataract surgery. National Health Service data suggested
that 62.3% of patients within 0.5D of the refractive target
should represent a minimum level of efficiency following
cataract surgery.23 Although this possibly represents the
lower end of achievable accuracy, we compare favourably
despite the higher potential risk profile of cataract surgery
in cases with long-standing glaucoma. Vector astigmatic
analysis suggested minor improvements although this may
have been ameliorated by the relatively low preoperative
refractive astigmatic values of our cohort (mean −0.91 ±
0.76D). Analysis of keratometric astigmatism will provide
additional evidence of the potential impact of iStent inject
insertion upon surgical-induced astigmatism.
Trabecular micro-bypass stenting has some inherent
advantages over other glaucoma surgical procedures.
Insertion of the iStent inject stents does not require the
use of additional incisions and wound stretch during the
stent insertion process is nominal, minimising the risk of
increasing surgically induced corneal change.10 With an
excellent safety profile, significant malposition of the stent
is unlikely and injection of the device into the supraciliary
space is rare, limited within the literature to a single case
report only24,25 Furthermore, the risk of iatrogenic damage
to the zonules with subsequent impact upon IOL position-
ing remains largely theoretical.24
The potential impact of the disease upon IOL power
calculations and outcomes may be generalised to all glau-
coma patients. Preoperatively, reduced vision due to glau-
comatous changes may impact the patient’s ability to
accurately fixate through biometry and related assess-
ments. With patients’ often on more than one topical
medication, subtle corneal surface sequelae due to the
ongoing preservative use are likely.26 Epitropoulos and
co-authors found that sub-clinical corneal changes could
impact the repeatability of keratometry readings poten-
tially affecting postoperative refractive outcomes.27
Although it is beyond the scope of this paper, considera-
tion of tear film and corneal surface optimisation prior to
biometry in glaucoma patients remains a plausible option
to further refine outcomes. Zonule laxity and IOL dislo-
cation in patients with pseudoexfoliation have been
described previously.28 The potential risk of subluxation
or excessive IOL movement is thereby increased. As
significant IOL tilt or decentration can impact both low
and higher-order aberrations affecting the potential refrac-
tive outcomes, a combined surgical approach may
heighten the risk if excessive manipulation is required.
Although unlikely to impact refractive endpoints, reduced
contrast sensitivity and pupillary dysfunction which
remain common in long-term glaucoma patients represent
a potential contraindication to the optimal use of multi-
focal or trifocal intraocular lenses.29,30 This represents
a further consideration during the preoperative counsel-
ling process as patients become more aware of available
IOL options.
Conclusion
We present a novel cohort of glaucoma patients under-
going combined trabecular micro-bypass stents (iStent
inject) and cataract surgery achieving excellent refractive
outcomes. Results suggest a minimal impact of the com-
bined approach or from the intrinsic risk profiles of
patients with mild to moderate co-existing disease. The
findings of this study suggest the device does not compro-
mise refractive outcomes and can safely be combined with
cataract surgery. Future prospective case–control studies
may provide additional evidence for refractive impact with
the iStent inject and other glaucoma devices.
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